XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2021 [1]   287,918      
Beginning balance at Jan. 31, 2021 $ 4,936,471 $ 28 [1] $ 6,175,425 $ 439 $ (1,239,421)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   7,082      
Issuance of common stock upon exercise of stock options 41,217 $ 2 [1] 41,215    
Issuance of common stock under employee stock purchase plan (in shares) [1]   259      
Issuance of common stock under employee stock purchase plan 26,398   26,398    
Vesting of early exercised stock options 215   215    
Vesting of restricted stock units (in shares) [1]   531      
Stock-based compensation 157,313   157,313    
Other comprehensive loss (73)     (73)  
Net loss (203,220)       (203,220)
Ending balance (in shares) at Apr. 30, 2021 [1]   295,790      
Ending balance at Apr. 30, 2021 4,958,321 $ 30 [1] 6,400,566 366 (1,442,641)
Beginning balance (in shares) at Jan. 31, 2022   312,377      
Beginning balance at Jan. 31, 2022 $ 5,049,045 $ 31 6,984,669 (16,286) (1,919,369)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 2,448 2,448      
Issuance of common stock upon exercise of stock options $ 15,130 $ 1 15,129    
Issuance of common stock under employee stock purchase plan (in shares)   184      
Issuance of common stock under employee stock purchase plan 26,094   26,094    
Issuance of common stock in connection with a business combination (in shares)   1,840      
Issuance of common stock in connection with a business combination 438,916   438,916    
Issuance of common stock in connection with a business combination subject to future vesting (in shares)   409      
Vesting of early exercised stock options 61   61    
Vesting of restricted stock units (in shares)   848      
Shares withheld related to net share settlement of equity awards (in shares)   (292)      
Shares withheld related to net share settlement of equity awards (54,145)   (54,145)    
Stock-based compensation 178,988   178,988    
Other comprehensive loss (30,301)     (30,301)  
Net loss (165,794)       (165,794)
Ending balance (in shares) at Apr. 30, 2022   317,814      
Ending balance at Apr. 30, 2022 $ 5,457,994 $ 32 $ 7,589,712 $ (46,587) $ (2,085,163)
[1] On March 1, 2021, all shares of the Company’s then-outstanding Class B common stock were automatically converted into the same number of shares of Class A common stock, pursuant to the terms of the Company’s amended and restated certificate of incorporation. No additional shares of Class B common stock will be issued following such conversion. See Note 10 for further details.